Why We’re Excited About Compass Pathways’ New Clinical Trial Treating PTSD with Psilocybin
Compass Pathways (Nasdaq: CMPS) has announced the launch of a…
compass pathways
Why Psychedelic Stocks Have Crashed in the Last 3 Months
Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.
Psychedelic Business Spotlight: September 17, 2021
This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility, and Awakn Life Sciences buys up ketamine clinics across the Nordics.
Psychedelic Business Spotlight: July 9, 2021
This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
End of content
End of content